Literature DB >> 1920459

Inhibition of lipid peroxidation in CNS trauma.

E D Hall1.   

Abstract

It is believed that the key mechanism of protection of the injured spinal cord by methylprednisolone (MP) is the inhibition of posttraumatic lipid peroxidation. Large, i.v. bolus doses are required to achieve this effect, but the biphasic dose-response curve limits the dose size to approximately 30 mg/kg. The mechanism for the reversed effect at higher concentrations is believed currently to be membrane disruption. Early treatment is required because injury mediated by lipid peroxidation is largely irreversible. Furthermore, the time course of the protective effects parallels the tissue pharmacokinetics, defining the need for repeated maintenance dosing by bolus or infusion. The optimum duration of treatment has not been ascertained, but it would appear to extend throughout the period during which biochemical conditions that promote peroxidation exist within the injured cord.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920459

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

1.  Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery.

Authors:  Samir P Patel; David H Cox; Jenna L Gollihue; William M Bailey; Werner J Geldenhuys; John C Gensel; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2017-03-30       Impact factor: 5.330

2.  Effect evaluation of methylprednisolone plus mitochondrial division inhibitor-1 on spinal cord injury rats.

Authors:  Xu-Gui Chen; Li-Hua Chen; Ru-Xiang Xu; Hong-Tian Zhang
Journal:  Childs Nerv Syst       Date:  2018-04-23       Impact factor: 1.475

Review 3.  Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses.

Authors:  Afsheen Raza; Nelli Karimyan; Amber Watters; Chitra P Emperumal; Kamal Al-Eryani; Reyes Enciso
Journal:  Support Care Cancer       Date:  2022-06-10       Impact factor: 3.603

4.  Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury.

Authors:  Samir P Patel; Patrick G Sullivan; Jignesh D Pandya; Alexander G Rabchevsky
Journal:  J Neurosci Res       Date:  2009-01       Impact factor: 4.164

5.  Effects of tumor necrosis factor alpha blocker adalimumab in experimental spinal cord injury.

Authors:  Alp Özgün Börcek; Soner Çivi; Özgür Öcal; Özlem Gülbahar
Journal:  J Korean Neurosurg Soc       Date:  2015-02-26

6.  Hyperbaric oxygen treatment of spinal cord injury in rat model.

Authors:  Yongming Sun; Dong Liu; Qingpeng Wang; Peng Su; Qifeng Tang
Journal:  BMC Neurol       Date:  2017-07-03       Impact factor: 2.474

7.  Effect of combined chondroitinase ABC and hyperbaric oxygen therapy in a rat model of spinal cord injury.

Authors:  Xiaoyang Liu; Jiefeng Wang; Guangkuo Li; Honglin Lv
Journal:  Mol Med Rep       Date:  2018-04-26       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.